Bio Sidus SA
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease (NCT05843916) | Bio Sidus SA | 2022-12-13 |
| PK/PD Study of 2 Agalsidase Formulations in Single Dose of 1 mg/kg Administered to Healthy Volunteers as IV Infusion (NCT05343715) | Bio Sidus SA | 2021-10-23 |
| Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease (NCT04036253) | Bio Sidus SA | 2018-02-28 |
Track Bio Sidus SA automatically
Every clearance here is in the API, with alerts when new ones post.